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Abstract
 .PGE1–lipid interactions were studied in several liposome systems. Data from both circular dichroic CD measurements
 .and differential scanning calorimetry DSC indicated that PGE1 in the protonated form seeks the less polar environment of
the lipid bilayer. CD measurements made on PGE1 in solution showed that the wavelength of maximum absorbance red
shifted approximately 8 nm with decreasing solvent polarity. The CD spectrum of liposomal PGE1 prepared in pH 4.5 but
not pH 7.2 buffer was also red shifted. There was no red shift in the CD spectrum of PGE1 detected at pH 4.5 in the
absence of phospholipid. DSC measurements on DSPC bilayers prepared with 5 mol% PGE1 at pH 4.5 but not pH 7.2
revealed an almost complete loss of the pre-transition as well as broadening of the main phase transition. The amount of
3H-PGE1 initially associated with EPC, POPC or DSPC liposomes was determined using size exclusion filters and
 .centrifugation. This amount was found to be dependent on the pH of the buffer pH 4.54pH 7.2 and fluidity of the
 .bilayer EPCsPOPC)DSPC , but independent of the lamellarity of the liposome. In all cases, addition of cholesterol
reduced the amount of PGE1 associated with the liposome. The time-dependent release of PGE1 from the liposomes was
determined by rapidly diluting the sample 100-fold into pH 7.2 buffer. Lipid saturation was a key factor influencing this
 .release. Gel-phase liposomes of DSPC showed a rapid initial release t -2 min of PGE1, corresponding to the amount1r2
in the outer monolayer, followed by a very slow, almost negligible release of the remaining PGE1. A rapid initial release
also occurred in fluid-phase membranes, followed by a more gradual release of the remaining PGE1 over several hours.
This release rate could be slowed by increasing the lamellarity of these liposomes, or adding cholesterol to decrease the
fluidity of the membrane. q 1997 Elsevier Science B.V.
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1. Introduction
Prostaglandins are a family of cyclic, oxygenated
fatty acids that exert diverse and potent effects on
cell function in many organ systems. In particular,
prostaglandins E and E have a well documented1 2
role in the series of events that encompass the inflam-
w xmatory cascade 1,2 . Since both pro- and anti-in-
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w xflammatory actions 3–11 have been attributed to
these molecules, it is likely that some therapeutic
uses could be expanded but these would undoubtedly
depend on the timing, dose and targeting of prosta-
glandins to their sites of action.
A major problem, however, exists regarding some
 .clinical uses of prostaglandin E PGE1 :1
When administered intravenously, this molecule is
rapidly metabolized during circulation through the
lungs, which results in an in vivo half-life of approxi-
w xmately 1 min 12 . In order to circumvent these
difficulties, considerable efforts have been made in
designing delivery vehicles for PGE1 that might pro-
long its in vivo half-life and deliver the molecule to
w xits site of action 13–18 . One area of research has
been in the design of lipid emulsions to improve the
w xchemical stability and retention of PGE1 14,16 .
Such formulations are reported to exhibit increased
biological activity and reduced side effects as com-
pared to the free drug in the treatment of peripheral
w xvascular diseases and diabetic neuropathy 19–21 .
Here we describe the physical characteristics of
various liposomal formulations as potential PGE1
delivery systems. This investigation has been fuelled
w xby encouraging preclinical 22–26 and clinical
w x27,28 results using liposomal PGE1 in the treatment
of a number of inflammatory diseases. The formula-
tion used in these studies consists of extruded 0.1
.mm liposomes prepared from EPC and PGE1 in a
200:1 molar ratio. At physiologic pH, the PGE1
rapidly dissociates from these vesicles. This combina-
tion of liposomes with PGE1 has been shown to
toggle the activity of PGE1 from pro- to anti-in-
w xflammatory in animal models 22,23 and has also
w xshown significant effect in clinical trials 27,28 .
Potentially, the preparation of liposomal PGE1 with
increased drug retention could provide access to the
treatment of other disease indications.
In this report we describe the association and
release characteristics of PGE1 in various liposomal
formulations. Factors such as pH, dilution, lipid com-
position and vesicle lamellarity were investigated.
2. Materials and methods
2.1. Chemicals
EPC, POPC, DSPC, DOPE-GA, DSPE-GA and
cholesterol were purchased from Avanti Polar Lipids
 . w  . 3 xAlabaster, AL . 5,6 n - H PGE1 was obtained from
 .Amersham Life Science Arlington Heights, IL and
PGE1 from Chinoin Pharm. and Chemical Works
 .Budapest, Hungary . HPLC grade solvents, methy-
lene chloride, chloroform and methanol were pur-
 .chased from Baxter McGaw Park, IL and sterile
0.9% saline from Abbott Laboratories North
.Chicago, IL . Acetic acid was obtained from Aldrich
 .Chemical Co. Milwaukee, WI and Hepes from
 .Sigma Chemical Co. St. Louis, MO . All lipids,
chemicals and solvents were used without further
purification.
2.2. Liposome preparation
 .Stable plurilamellar vesicles SPLVs of EPC,
POPC or DSPC and PGE1 were prepared by a varia-
w xtion of the method of Gruner et al. 29 . Briefly, the
phospholipid and PGE1 were mixed in organic sol-
 .vent CHCl , CH Cl , ethanol and 3% of the total3 2 2
buffer volume 50 mM sodium acetate, pH 4.5, 0.9%
.saline was added. The solvent was evaporated under
a continuous stream of nitrogen until a wet lipid paste
formed. This paste was then hydrated with buffer to
the desired volume. Typical concentrations were 10
mgrml phospholipid and 25 mgrml PGE1. The
SPLVs were then extruded under pressure 10 times
through 14 mm polycarbonate filters using a Lipex
extruder Lipex Biomembranes Corp., Vancouver,
.BC . For DSPC SPLVs, the hydration and extrusion
steps were performed in 10 mM sodium acetate, pH
4.5, 0.9% saline at 708C. Samples were radioactively
3 labeled by adding small quantities of H-PGE1 0.4
.mCirml in ethanol to the organic phase before
evaporation. For samples containing either choles-
 .  .terol 10, 30 or 40 mol% , DOPE-GA 10 mol% or
 .  .DSPE-GA 10 mol% , these lipids in CHCl were3
added to the organic solvent phase and the POPC or
DSPC molar concentration was reduced appropri-
ately. All liposome preparations used in the release
assays had a molar ratio of total lipid to PGE1 of
200:1. To determine the apparent partition coefficient
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of liposomal and aqueous PGE1 at pH 4.5, samples
were made at 0.5–8 mol% PGE1 by holding the
PGE1 concentration constant at 25 mgrml and de-
creasing the lipid concentration.
Unilamellar liposomes of DSPC were made by
combining phospholipid and PGE1 in organic solvent
then drying by rotary evaporation. Multilamellar vesi-
cles were formed from this film by adding buffer 10
.mM sodium acetate, 0.9% saline, pH 4.5 and incu-
bating at 708C for 30 min, vortexing periodically.
Typical concentrations were 4 mgrml phospholipid
and 10 mgrml PGE1. After 10 freezerthaw cycles,
the sample was extruded 10 times through two-stacked
0.1 mm polycarbonate filters at 708C. Unilamellar
liposomes of EPCrPGE1 were made in a similar
way, except the lipid film was hydrated in 50 mM
sodium acetate, and all steps were carried out at room
temperature. Vesicle size was confirmed by quasi-
elastic light scattering using a Nicomp Model 270
submicron particle sizer Nicomp Instruments, Inc.,
.Goleta, CA .
2.3. Circular dichroic measurements of PGE1
Circular dichroic measurements of PGE1 were
made using a JASCO J-710 Spectropolarimeter Japan
.Spectroscopic Co., Tokyo . Spectra were obtained
between 250 nm and 350 nm in order to monitor the
n“p ) transition of the carbonyl group of PGE1.
For these experiments, liposomes composed of EPC
 .  .2 mgrml and PGE1 50 mgrml were prepared via
extrusion through 50 nm polycarbonate filters. Small
extruded liposomes were used for these experiments
in order to minimize light scattering. Samples were
prepared in 50 mM sodium acetate, 0.9% saline pH
. 4.5 , as well as in 10 mM Hepes, 0.9% saline pH
.7.2 . CD measurements were made at room tempera-
ture using a 10 mm path length quartz cell and a
scanning speed of 50 nmrmin. A minimum of eight
scans was collected for each sample. Appropriate
blanks were subtracted before reporting molar circu-
 2 .lar-dichroic absorbance cm rmmol .
2.4. Differential scanning calorimetry
Phase transition temperatures of multilamellar
vesicles were determined using a differential scan-
ning calorimeter Microcal MC-2 with DA-2 data
.acquisition software, Northampton, MA . Multilamel-
lar vesicles were prepared by dispersing a thin film of
 .DSPC 100 mg in the absence and presence of PGE1
 . 2.5 mg in 25 ml of 10 mM acetate buffer 150 mM
.NaCl, pH 4.5 . The lipid was hydrated at 658C for 0.5
h. Their melting behavior was measured using that
same buffer solution as a reference. Heating and
cooling scans were recorded from 108C to 658C at a
rate of 208Crh. Samples were equilibrated at the
starting temperature for at least 1 h prior to each
scan.
2.5. NMR spectroscopy
Measurements were completed on a Bruker AC300
spectrometer operating at 121.5 MHz. In a typical
experiment, the 31P signals were collected using a 908
pulse of 15 ms for the total 3000 transients. The
gated proton decoupler was used to suppress phos-
phorus–proton couplings with exponential line broad-
ening of 50 Hz applied to all FIDs. EPC 50
.  .mgrml rPGE1 125 mgrml SPLVs were made as
described above. Samples were then extruded 10
times through a 14 mm or 0.8 mm polycarbonate
filter. In addition, one sample was frozen and thawed
10 times then extruded through a 0.1 mm filter. The
lamellarity of the liposomes was determine by titrat-
2q  .ing the relaxation agent Mn as MnCl into each2
w xsample 30 , and recording spectra at each titration
point. The integrated area of the EPC peak was
determined relative to an external triphenyl phosphite
standard. The percent of total lipid exposed to the
bulk aqueous phase was calculated from the ratio of
EPC area at saturating Mn2q to EPC area at 0 mM
Mn2q.
2.6. Measurement of initial association and release of
PGE1 from liposomes
The amount of PGE1 initially incorporated into the
liposomes was determined using 3H-PGE1. Lipo-
somes and associated PGE1 were separated from
bulk buffer and unassociated PGE1 by centrifugation
using Centricon-30 microconcentrators Amicon,
.Beverly, MA in a fixed-angle rotor at 3000–5000=g
for 15–60 min at 238C. Aliquots of the starting
liposome preparation and the lipid-free filtrate were
counted on a LS6800 liquid scintillation counter Be-
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.ckman Instruments, Irvine, CA . The percentage of
PGE1 associated with the liposome was calculated
from the radioactivities in the filtrate and the starting
sample.
The time-dependent release of PGE1 from lipo-
somes after dilution was determined by rapidly mix-
ing 1 ml of the tritiated sample with 100 ml of 10
mM Hepes, 0.9% saline, pH 7.2. PGE1 is monomeric
under neutral 0–0.4 mM, the highest concentration
.  .is a saturated solution as well as basic 0–45 mM
w xconditions 31 . All experiments were performed at
room temperature, except those using DPPC MLVs at
558C, as noted. Aliquots were removed at various
time points ranging from 3 min to 20 h. The lipo-
some-associated and non-associated PGE1 were sepa-
rated by centrifugation in a fixed-angle rotor at
5000–8000=g for 1–2 min using either Centricon-
30 or Microcon-100 microconcentrators Amicon,
.Beverly, MA . No difference was found between the
two types of concentrators or speed of centrifugation.
The microconcentrators were also tested using radio-
labeled liposomes to ensure that the filtrate did not
contain PGE1 that was still liposome-associated. The
percentage of PGE1 that remained associated with
the liposomes was calculated as described above for
initial incorporation. Control experiments were also
performed in order to ensure that the PGE1 release
profiles were indicative of the kinetics of PGE1
release, not PGE1 equilibration. A 50-fold and a
250-fold dilution were substituted for the 100-fold
dilution. Under both of these conditions, the same
release profiles were obtained.
3. Results and discussion
3.1. PGE1 associates with lipid membranes at pH 4.5
 .Circular dichroic CD measurements of optically
active carbonyl compounds, such as PGE1, are known
w xto be sensitive to solvent environment 32 . Specifi-
cally, the n“p ) transition of the carbonyl group is
red shifted with decreasing solvent polarity. The ab-
sence of hydrogen bonding in nonpolar solvents raises
the energy level of the n orbital, thus decreasing the
n“p ) transition energy. We hypothesized that this
property could be used as an indicator of liposomal
PGE1 environment surface vs. intra-membrane asso-
Fig. 1. Circular dichroic spectra of ‘free’ and liposomal PGE1.
 .  .a Circular dichroic spectra of PGE1 50 mgrml dissolved in
 .  .ethanol - - - , hexane – P P – and aqueous buffers at pH 4.5
 .  .and pH 7.2 PPP . The vibrational fine structure
evident in the CD spectrum of PGE1 dissolved in hexane has
been observed for other carbonyl compounds in hydrocarbon
w x  .solvents 32 . b Circular dichroic spectra of liposomal PGE1 in
 .  .aqueous buffers at pH 4.5 and pH 7.2 PPP . In both
cases, the LUV dispersion was prepared by extrusion through 50
 .nm polycarbonate filters and consisted of EPC 2 mgrml and
 .PGE1 50 mgrml .
.ciation . CD spectra of free and liposomal PGE1
were obtained between 250 nm and 350 nm, as
shown in Fig. 1. As expected, the wavelength of
maximum absorbance of free PGE1 red shifted ap-
proximately 8 nm with decreasing solvent polarity.
The magnitude of this shift is typical of that seen
w xwith other carbonyl compounds 32 . The wavelength
of maximum absorbance of free PGE1 in aqueous
buffer remained unchanged at pH 4.5 or pH 7.2. In
 .contrast, the CD spectra of liposomal PGE1 Fig. 1b ,
was dependent on the pH of the buffer used to
prepare the sample. The spectrum in pH 7.2 buffer
was very similar to that of free PGE1 in buffer at pH
 .7.2 or pH 4.5. In this case, very little 9% of the
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PGE1 was liposome associated detected using triti-
.ated PGE1 . At pH 4.5 however, where approxi-
mately 80% of the PGE1 was found to be associated
with the liposome, the spectrum was red shifted. This
data indicates that, at pH 4.5, PGE1 locates within
the lipid bilayer. In these fluid-phase membranes the
bulk of the PGE1 molecule likely resides primarily in
the head group region with the hydrophobic C end20
penetrating to approximately the C –C region of the2 5
bilayer. The pK of PGE1 in water is reported to bea
w x4.8, as determined by methanol–water titrations 33 .
Thus, at pH 7.2 PGE1 exists predominantly as the
carboxylate anion. Significant liposome association is
only achieved at lower pH where a larger percentage
of PGE1 is protonated and incorporation into the
lipid membrane of the less water-soluble species
becomes thermodynamically favorable.
Further evidence of PGE1 membrane association
was provided from differential scanning calorimetry
experiments gathered from multilamellar vesicles
 .composed of DSPC 4 mgrml prepared in 10 mM
 .  .sodium acetate pH 4.5 in 0.9% saline Fig. 2 .
PGE1 decreased the main phase transition tempera-
ture of DSPC by 0.58C and increased the peak width
at half-height by five-fold. The pre-transition was
almost completely obliterated. This is typical of
changes that can occur when a perturbing molecule is
w xpresent within the bilayer 34–37 . When we per-
formed the same experiments using liposomes pre-
 .pared in pH 7.2 Hepes buffer data not shown , the
main phase transition of DSPC was unaffected but
Fig. 2. High-sensitivity excess heat capacity profiles of DSPC
 .  .bilayers in the absence and presence - - - of PGE1.
MLVs were prepared in 10 mM acetate buffer 150 mM NaCl,
.pH 4.5 . The sub-main phase transition evident in both DSC
w xtraces is caused by a salt effect 55,56 .
 .Fig. 3. PGE1 partitions between aqueous and organic lipid
phases. Plot of the log of the partition ratio as a function of PGE1
concentration in the aqueous phase. EPCrPGE1 SPLVs in 50
 .mM sodium acetate in 0.9% saline pH 4.5 were prepared such
that the lipid concentration varied from 10 to 0.6 mgrml while
the PGE1 concentration was held constant at 25 mgrml. Each
preparation was labeled with tritiated PGE1 in order to determine
 .the extent of liposome association as described in Section 2 .
This data is shown in the inset chart. The apparent partition
coefficient, K , was determined for each preparation using theapp
concentration of PGE1 found in the aqueous and lipid phases.
 .the pre-transition was lowered slightly 18C . Using
tritiated preparations, we found that in these cases
only approximately 10% of the PGE1 was liposome-
associated. This low level of association was either
insufficient to cause observable endotherm broaden-
ing or the deprotonated molecule bound only to the
interfacial regions of the membrane causing no dis-
ruption of acyl-chain packing.
The partitioning behavior of PGE1 between im-
 .miscible organic lipid and aqueous phases is shown
in Fig. 3 for EPCrPGE1 SPLVs in 50 mM sodium
 .acetate in 0.9% saline pH 4.5 . Partition coefficients
measured for PGE1 in several liposomal preparations
are tabulated in Table 1. In each case the lipid
concentration varied from 10 to 0.6 mgrml while the
Table 1
PGE1 apparent partition coefficients in several liposomal formu-
lations
Liposome formulation Kapp
2DSPC-MLV 7.4=10
2 .DSPCrCHOL 90:10 -MLV 3.1=10
3EPC-SPLV 1.5=10
3EPC-MLV 2.4=10
3 .EPCrCHOL 90:10 -MLV 1.6=10
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PGE1 concentration was held constant at 25 mgrml.
Each preparation was labeled with tritiated PGE1 in
order to determine the extent of liposome association.
The apparent partition coefficient:
K s PGE1 r PGE1lipid aqapp
was determined for each preparation using the con-
centration of PGE1 found in the aqueous and lipid
phases. These calculations were made using values of
0.983 mlrg and 0.952 mlrg for the specific volume
w x w xof EPC 38 and DSPC 39 , respectively, and a value
of unity for the activity coefficient.
The apparent partition coefficients measured for
fluid-phase bilayers composed of EPC or
EPCrcholesterol agreed well with the octanol–water
partition coefficient of PGE1 measured at pH 4.5 by
w x  .Avdeef et al. 33 . A significant decrease 3–8-fold
in PGE1 partitioning was observed in DSPC or
DSPCrcholesterol gel-phase bilayers. This decrease
is a likely consequence of the increased surface den-
sity of the bilayer chains, which leads to solute
w xexclusion 40,41 .
3.2. The association of PGE1 with liposomes pre-
pared in pH 4.5 buffer is dependent upon the lipid
composition
As predicted by the apparent partition coefficients
measured for PGE1 in fluid- and gel-phase mem-
branes, the degree of association of PGE1 with lipo-
somes prepared in pH 4.5 buffer was found to depend
 .upon lipid composition Table 2 . PGE1 was more
highly incorporated into fluid unsaturated EPC or
.  .POPC than gel-phase saturated DSPC bilayers. It is
not surprising that fluid-phase lipid membranes with
a higher degree of alkyl-chain disorder accommodate
the functionalized cyclopentane ring of PGE1 more
effectively than tightly packed and highly ordered
gel-phase membranes.
Cholesterol reduced PGE1 association only slightly
in fluid-phase bilayers but quite significantly in gel-
phase bilayers note the 2-fold decrease in K forapp
DSPCrcholesterol bilayers as compared to DSPC
.bilayers in Table 1 . We suspect that the fused-ring
structure of cholesterol in combination with gel-phase
lipid is highly dimensionally uncomplimentary to that
of PGE1. The fluidizing effect that cholesterol has on
w xgel-phase lipid 42 was overshadowed by these geo-
metric constraints.
Table 2
Percentage of PGE1 initially associated with various liposome
formulations
aLiposome formulation PGE1 associated
 .%
bDSPC-LUV 68"1
cDSPC-SPLV 84"1
b .DSPCrDSPE-GA 90:10 -LUV 72"1
b .DSPCrCHOL 90:10 -LUV 45"1
b .DSPCrCHOL 60:40 -LUV 7"2
cEPC-LUV 94"3
c,dEPC-SPLV 94"1
c,eEPC-SPLV 94"1
cPOPC-SPLV 95"2
c .POPCrDOPE-GA 90:10 -SPLV 93"3
c .POPCrCHOL 90:10 -SPLV 93"2
c .POPCrCHOL 70:30 -SPLV 78"3
a Formulations at total lipid:PGE1 mol ratio of 200:1.
b 10 mgrml PGE1.
c 25 mgrml PGE1.
d EPC SPLV with 10% of total phospholipid located in the outer
leaflet.
e EPC SPLV with 20% of total phospholipid located in the outer
leaflet.
The effect of negative surface charge on PGE1
incorporation was investigated by the addition of the
phospholipid derivatives DSPE-GA or DOPE-GA into
liposomes prepared from saturated and unsaturated
lipids, respectively. These preparations were of inter-
est to us from an experimental as well as a practical
point of view because these lipid derivatives are
known to increase the circulation lifetime of lipo-
w xsomes in vivo 43,44 . As shown in Table 2, the
addition of 10 mol% of these negatively charged lipid
derivatives had no effect on the degree of PGE1
incorporation.
Association was also independent of liposome
lamellarity, as shown by the identical incorporation
of PGE1 into EPC LUVs and SPLVs. A slightly
higher PGE1 association is reported for DSPC SPLVs
than LUVs because the SPLVs were prepared at a
higher concentration.
3.3. The dissociation of PGE1 from liposomes at
physiologic pH is dependent upon liposome lamellar-
ity and lipid composition
The release of PGE1 from liposomes prepared in
either 10 or 50 mM sodium acetate and 0.9% saline
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 .pH 4.5 was measured using a method that relies
upon a 100-fold dilution of the sample into a pH 7.2
Hepes buffer. These conditions were chosen in order
to mimic the pH change and rapid sample dilution
that would occur in vivo. Results from these experi-
ments are shown in Fig. 4. We studied the release of
PGE1 from EPC LUVs that were prepared by extru-
sion through 0.1 mm filters. Quasi-elastic light scat-
tering measurements revealed them to have a mean
diameter of approximately 91 nm. The integration of
31P-NMR spectra in the absence and presence of
Mn2q revealed approximately 43% of the total phos-
pholipid was located in the outer leaflet. Release of
PGE1 from these single lamellar liposomes was rapid
and essentially complete within 3 min, which was the
first convenient measurement point. Upon dilution
into pH 7.2 buffer, the PGE1 putatively located in the
outer leaflet was rapidly deprotonated, becoming
much more soluble in the aqueous phase. PGE1
Fig. 4. Dissociation of PGE1 from liposomes at physiologic pH
depends upon liposome lamellarity and lipid composition. PGE1
 .  .release profiles from DSPC SPLVs ‘ and LUVs I , DPPC
 .  .  .  .MLVs rt i and 558C d , EPC SPLVs with 10% ’ and
 .20% v of total phospholipid located in the outer leaflet, EPC
 .LUVs with 43% l of total phospholipid located in the outer
leaflet. Lamellarity calculations are based on the integration of
31P-NMR spectra in the absence and presence of Mn2q. In all
cases, 1 ml of the preparation was rapidly diluted with 100 ml of
 .10 mM Hepes in 0.9% saline pH 7.2 . Aliquots were removed at
 .various time points 3 min to 20 h and the liposome-associated
and non-associated PGE1 were separated by centrifugation using
microconcentrators. Data is plotted as the percentage of PGE1
remaining associated with the liposome as a function of time. The
graphs are not normalized; 100% retention is equal to the total
amount of PGE1 initially present liposome associated and non-
.associated in each preparation. In each case, the percentage of
PGE1 initially associated with the liposome was 94%, except
where noted in parentheses.
located in the inner leaflet was also rapidly released
from the vesicle, which indicates that in this situation
there was virtually no barrier to PGE1 ‘flip-flop’
across the membrane.
Similar rapid release of PGE1 from 200 nm lipid
 . w xmicrospheres Lipo-PGE1 has been reported 45 .
 .Lipo-PGE1 is a 10% oil in water pH 4.5–6.0
emulsion prepared from soyabean oil, EPC and other
components. The release of PGE1 from these micro-
spheres was determined by ultrafiltration in a similar
manner to the method we report here and was found
to be over 90%. Conflicting results using a dialysis
method to measure PGE1 release from Lipo-PGE1
w xhave also been reported 13,46 . In this case, Lipo-
PGE1 was enclosed in cellulose tubing and immersed
 .into pH 7.4 buffer 10-fold increase in volume at
208C. In these studies only 50% of the PGE1 was
released after 2 h but the rate-limiting step was
probably diffusion through the cellulose membrane
not release of PGE1 from the lipid microspheres. We
have found that equilibration of free PGE1 across
dialysis membranes requires extended time frames
 .t)60 min .
PGE1 release kinetics from DSPC LUVs were in
marked contrast to the release profile from EPC
 .LUVs Fig. 4 . LUVs prepared from DSPC released
only approximately 50% of the initially associated
PGE1. After this rapid release phase the remaining
fraction of PGE1 ca. 48% of initially associated
.PGE1 remained associated for )5.5 h. Presumably,
PGE1 exposed to the pH 7.2 buffer in the outer
leaflet was rapidly deprotonated and released from
the membrane. PGE1 located in the interior leaflet
was rigidly embedded in the tightly packed gel-phase
 .lipid and transbilayer movement ‘flip-flop’ across
the membrane is essentially abolished.
The release kinetics of PGE1 from multilamellar
fluid- and gel-phase membranes are also shown in
Fig. 4. Release profiles of PGE1 from EPC SPLVs
with 10% or 20% of total phospholipid located in the
 31 .outer leaflet data from P-NMR showed a rapid
initial release of PGE1, followed by a more gradual
release over a period of several hours. DSPC SPLVs
showed long-term retention of the bulk of the initially
.associated PGE1 . Clearly, liposome lamellarity plays
a significant role in the retention of PGE1. For
multilamellar vesicles, the majority of PGE1 is lo-
cated within internal lipid membranes. Release of the
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drug requires crossing multiple aqueous compart-
ments and lipid bilayers, which greatly attenuates its
release from fluid-phase systems. For gel-phase sys-
tems the fraction of PGE1 located in internal lamellae
is apparently unable to gradually migrate through
successive bilayers, only material in the outer leaflet
is released. This conclusion is supported by data
collected on the release of PGE1 from DPPC MLVs
 .at room temperature and 558C Fig. 4 . Below the
phase transition these liposomes showed long-term
retention of the bulk of the initially associated PGE1,
similar to the DSPC SPLVs. However, above the
phase transition a rapid release phase is followed by a
gradual release over a period of several hours, similar
to fluid-phase EPC multilamellar membranes. These
results strongly support our conclusion that the rate
of transbilayer movement of PGE1 is greatly influ-
enced by the physical state of the membrane.
The effect of lipid composition on PGE1 dissocia-
tion was further investigated for POPC and DSPC
liposomes that incorporated cholesterol or negative
surface charge. The addition of increasing amounts of
cholesterol to POPC SPLVs decreased the PGE1
release rate, particularly the initial rapid release phase,
 .from these systems Fig. 5a . The effect of choles-
terol on lipid bilayers has been extensively studied
w x47–53 . In a membrane above its phase transition,
cholesterol reduces the freedom of the lipid acyl
chains. This results in bilayers that are more tightly
packed and less fluid, more like a membrane com-
posed of lipids that are in the gel phase. Dissociation
of PGE1 from this type of membrane is more diffi-
cult, as previously determined for gel-phase DSPC
bilayers.
On the other hand, addition of increasing amounts
of cholesterol to DSPC LUVs had a profound effect
on the ability of PGE1 to be incorporated into these
 . membranes Table 2 but no effect on release Fig.
.5b . The release profiles were identical, after consid-
ering the amount of PGE1 initially associated in each
liposome preparation. In all cases approximately 50%
of the PGE1 was rapidly released and the remaining
fraction had long-term retention. Of course, in
 .DSPCrcholesterol 60r40 LUVs, virtually no PGE1
was initially associated with this membrane.
Incorporation of DOPE-GA or DSPE-GA into li-
posomes had only a slight effect on the rate of PGE1
 .release data not shown . Both POPC SPLVs, pre-
 .Fig. 5. Effect of cholesterol on PGE1 release. a PGE1 release
 .  .profiles from POPC SPLVs prepared with 0% l , 10% B ,
 .  .and 30% ’ cholesterol. b PGE1 release profiles from DSPC
 .  .  .LUVs prepared with 0% l , 10% B , and 40% ’ choles-
terol. Experimental conditions are the same as described in Fig.
4. The value in parentheses is the percentage of PGE1 initially
associated with the liposome.
pared with 10 mol% DOPE-GA, and DSPC LUVs,
prepared with 10 mol% DSPE-GA, showed a slight
increase in the initial rate of release of PGE1 from
the membrane as compared to POPC SPLVs or DSPC
LUVs prepared without these lipid derivatives. In
both cases, approximately 35% of the initially associ-
ated PGE1 remained with the liposome at the first
 .time point measured 3 min . After this rapid initial
release the data were identical to the underivatized
liposomes in both cases. This small increase in the
initial rate of PGE1 release was likely due to charge
repulsion or the change in liposome morphology
produced by the incorporation of these molecules
w x54 .
4. Conclusions
We have shown that protonated PGE1 associates
with lipid membranes and the degree of this associa-
tion is highly compositionally dependent. The disso-
( )S.M.K. Da˝idson et al.rBiochimica et Biophysica Acta 1327 1997 97–106 105
ciation of PGE1 from such systems was measured
using rapid dilution at physiologic pH and could be
related to the degree of lipid saturation, lamellarity
and negative surface charge in a systematic fashion.
Fluid-phase membranes accommodated more PGE1
than gel-phase membranes. Addition of cholesterol
reduced the ability of both fluid- and gel-phase mem-
branes to accommodate this molecule. At physio-
logical pH values PGE1 embedded in gel-phase
membranes showed greatly reduced release kinetics
compared to PGE1 embedded in fluid-phase mem-
branes.
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